This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Factors Affecting Early Progress of Cochlear Implant Outcomes in Adults

Sponsored by Cochlear

About this trial

Last updated a year ago

Study ID

EMEA5798

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 3 years ago

What is this trial about?

The aim of this study is to understand how audiometric, cognitive and electrophysiological results relate to sentence recognition score in adults using currently a Nucleus cochlear implant.

What are the participation requirements?

Yes

Inclusion Criteria

- Adult subjects, 18 years or older

- Subjects unilaterally implanted or bilaterally implanted with at least 6 months separating the two cochlear implantations.

- Subjects who have been implanted between January 2016 and December 2021.

- Subjects have received a Nucleus CI: CI512, CI522 or CI532 cochlear implants with non-rotating magnet, or CI600 series equivalent CI612, CI622 and CI632 with rotating magnet and external sound processors CP900 or CP1000 behind-the-ear, or Kanso or Kanso 2 off-the-ear types.

- Subjects who are fluent in French (language used in the questionnaire and speech tests)

- Subjects who are not opposed to participating in the study

- Subjects for who the medical record data is available throughout the defined data search period.

No

Exclusion Criteria

- Subjects with single-sided deafness (SSD).

- Subjects who are not affiliated to the French Social Security.

- Subjects who are under legal protection.

Locations

Location

Status